返回 Agenda
SESSION 7: META ANALYSIS
Session Chair(s)
Kerry Gordon
Senior Director, Biostatistics, Japan, China, Europe and North America
IQVIA, United Kingdom
James Matcham
Head, Early Clinical Development Biometrics
AstraZeneca, United Kingdom
The objective of this session is to describe how to combine results from different trials. In addition, we will review the limitations of a meta-analysis and how to interpret the results of such an analysis.
- Literature searches
- Methods for combining results
- Study-level vs patient-level analyses
- Interpretation
- Use in indirect comparisons
Speaker(s)
META ANALYSIS
James Matcham
AstraZeneca, United Kingdom
Head, Early Clinical Development Biometrics